New Chromsystems Product for Antiepileptic Drugs Testing
Chromsystems announces the launch and immediate availability of the MassTox® TDM Series A Parameter Set Antiepileptic Drugs XT2 in Serum/Plasma – All-in-One Method. The updated parameter set extends the MassTox® TDM portfolio, helping laboratories meet clinical needs and regulatory requirements in therapeutic drug monitoring.













